Technical Analysis for EDSA - Edesa Biotech, Inc.

Grade Last Price % Change Price Change
D 6.0 -8.40% -0.55
EDSA closed down 8.4 percent on Wednesday, May 5, 2021, on 1.41 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: May 13
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical EDSA trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 200 DMA Bullish -8.40%
Expansion Breakout Bullish Swing Setup -8.40%
Pocket Pivot Bullish Swing Setup -8.40%
Volume Surge Other -8.40%
Wide Range Bar Range Expansion -8.40%
Older End-of-Day Signals for EDSA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below 10 DMA about 8 hours ago
Down 10% about 9 hours ago
Possible Inside Day about 10 hours ago
10 DMA Support about 10 hours ago
Down 1 ATR about 10 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on efficiently developing innovative treatments that address significant unmet medical needs. Edesa's lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis which has demonstrated statistically significant improvements in multiple clinical studies. Edesa also intends to expand the utility of its sPLA2 inhibitor technology, which forms the basis for EB01, across multiple indications. The company is based in Toronto, Canada, with U.S. offices in Southern California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Industry Medication Dermatitis

Is EDSA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.1
52 Week Low 2.45
Average Volume 260,197
200-Day Moving Average 6.15
50-Day Moving Average 5.56
20-Day Moving Average 5.64
10-Day Moving Average 5.92
Average True Range 0.54
ADX 19.67
+DI 31.55
-DI 12.37
Chandelier Exit (Long, 3 ATRs ) 5.61
Chandelier Exit (Short, 3 ATRs ) 6.54
Upper Bollinger Band 6.46
Lower Bollinger Band 4.81
Percent B (%b) 0.72
BandWidth 29.18
MACD Line 0.15
MACD Signal Line 0.07
MACD Histogram 0.0816
Fundamentals Value
Market Cap 57.65 Million
Num Shares 9.61 Million
EPS -5.79
Price-to-Earnings (P/E) Ratio -1.04
Price-to-Sales 157.51
Price-to-Book 9.53
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.24
Resistance 3 (R3) 7.32 6.98 7.03
Resistance 2 (R2) 6.98 6.67 6.94 6.96
Resistance 1 (R1) 6.49 6.47 6.33 6.41 6.89
Pivot Point 6.16 6.16 6.08 6.12 6.16
Support 1 (S1) 5.67 5.84 5.50 5.59 5.11
Support 2 (S2) 5.33 5.65 5.29 5.04
Support 3 (S3) 4.84 5.33 4.97
Support 4 (S4) 4.76